AGENCE D`ÉVALUATION DE L`ENSEIGNEMENT SUPERIEUR

Transcription

AGENCE D`ÉVALUATION DE L`ENSEIGNEMENT SUPERIEUR
ECOPHAM - DYNAMYC
Articles in international journals
N=67
Research articles
2008
1. Botterel F, Farrugia C, Ichai P, Costa JM, Saliba F, Bretagne S. Real-time PCR on the first galactomannan-positive
serum sample for diagnosing invasive aspergillosis in liver transplant recipients. Transpl Infect Dis, 2008;10(5):333-8.
2. Botterel F, Gross K, Ibrahim-Granet O, Khoufache K, Escabasse V, Coste A, Cordonnier C, Escudier E, Bretagne S.
Phagocytosis of Aspergillus fumigatus conidia by primary nasal epithelial cells in vitro. BMC Microbiol, 2008;18(8):97.
3. Desnos-Ollivier M, Bretagne S, Bernède C, Robert V, Raoux D, Chachaty E, Forget E, Lacroix C, Dromer F; Yeasts
Group. Clonal population of flucytosine-resistant Candida tropicalis from blood cultures, Paris, France. Emerg Infect
Dis. 2008. 14(4):557-65.
4. Desnos-Ollivier M, Bretagne S, Raoux D, Hoinard D, Dromer F, Dannaoui E; European Committee on Antibiotic
Susceptibility Testing. Mutations in the fks1 gene in Candida albicans, C. tropicalis, and C. krusei correlate with
elevated caspofungin MICs uncovered in AM3 medium using the method of the European Committee on Antibiotic
Susceptibility Testing. Antimicrob Agents Chemother, 2008;52(9):3092-8.
2009
5. Alekseeva L, Huet D, Féménia F, Mouyna I, Abdelouahab M, Cagna A, Guerrier D, Tichanné-Seltzer V, Baeza-Squiban
A, Chermette R, Latgé JP, Berkova N, Inducible expression of beta defensins by human respiratory epithelial cells
exposed to Aspergillus fumigatus organisms. BMC Microbiology, 2009. 9:33.
6. Bellanger AP, M.L., Khoufache K, Rivollet D, Bièche I, Laurendeau I, Vidaud M, Botterel F, Bretagne S, Aspergillus
fumigatus germ tube growth and not conidia ingestion induces expression of inflammatory mediator genes in the
human lung epithelial cell line A549. Journal of Medical Microbiology, 2009. 58:174-179.
7. Cordonnier C, Botterel F, Ben Amor R, Pautas C, Maury S, Kuentz M, Hicheri Y, Bastuji-Garin S, Bretagne S,
Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with
invasive aspergillosis. Clin Microbiol Infect 2009. 15(1):81-86.
8. Cordonnier C, PC, Maury S, Vekhoff A, Farhat H, Suarez F, Dhedin N, Isnard F, Ades L, Kuhnowski F, Foulet F, Kuentz
M, Maison P, Bretagne S, Schwarzinger M, Empirical versus preemptive antifungal therapy for high-risk, febrile,
neutropenic patients: a randomized, controlled trial. Clin Infect Dis, 2009, 48(8):1042-1051.
9. de Valk HA, M JF, Bretagne S, Costa JM, Lasker BA, Balajee SA, Pasqualotto AC, Anderson MJ, Alcazar-Fuoli L,
Mellado E, Klaassen CH, Interlaboratory reproducibility of a microsatellite-based typing assay for Aspergillus
fumigatus through the use of allelic ladders: proof of concept. Clinical Microbiology Infection 2009. 15(2):180-187.
10. Féménia F, Huet D, Lair-Fulleringer S, Wagner C, Sarfati S, Shingarova L, Guillot J, Boireau P, Chermette R, Berkova
N, Effect of conidia of various Aspergillus species on apoptosis of human pneumocytes and bronchial epithelial cells.
Mycopathologia 2009. 167:249-262.
11. Fréalle E, DK, Botterel F, Bouchindhomme B, Camus D, Dei-Cas E, Costa JM, Yakoub-Agha I, Bretagne S, Delhaes L,
Diagnosis of invasive aspergillosis using bronchoalveolar lavage in haematology patients: influence of bronchoalveolar
lavage human DNA content on real-time PCR performance. Eur J Clin Microbiol Infect Dis 2009. 28(3):223-232.
12. Lamarre C, BR, Balloy V, Fontaine T, Wong Sak Hoi J, Guadagnini S, Berkova N, Chignard M, Beauvais A, Latgé JP,
Galactofuranose attenuates cellular adhesion of Aspergillus fumigatus. Cell Microbiol, 2009. 11(11):1612-1623.
13. Nieguitsila A, Goldenberg O, Deville M, Arné P, Benoit-Valiergue H, Chermette R, Latouche-Cottenot S, Pissard S,
Guillot J, Molecular monitoring of fungal communities in air samples by denaturing high-performance liquid
chromatography (D-HPLC). Journal of Applied Microbiology, 2010. 111:248-253.
14. Svirshchevskaya EV, S.M., Huet D, Féménia F, Latgé JP, Boireau P, Berkova N, Susceptibility of mice to invasive
aspergillosis correlates with delayed cell influx into the lungs. Int J Immunogenet, 2009. 36(5):289-299.
2010
15. Botterel F, Foulet F, Legrand P, Soria AM, Farrugia C, Grimbert P, Matignon M, Lauzet JY, Guerrini P, Bretagne S,
Yeast contamination of kidney, liver and cardiac preservation solutions before graft: need for standardisation of
microbial evaluation. J Hosp Infect, 2010. 76(1):52-55.
16. Cabaret O, P.O., Botterel F, Pean M, Khoufache K, Costa JM, Delaforge M, Bretagne S, Metabolic detoxication
pathways for sterigmatocystin in primary tracheal epithelial cells. Chem Res Toxicol, 2010. 23(11):1673-1681.
17. Costa JM, G.-H.D., Olivi M, Cabaret O, Farrugia C, Lecellier G, Dromer F, Bretagne S, Genotyping of Candida albicans
using length fragment and high-resolution melting analyses together with minisequencing of a polymorphic
microsatellite locus. Journal of Microbiological Methods, 2010. 80(3):306-309.
18. Dannaoui E, P.A., Develoux M, Chochillon C, Matheron J, Datry A, Bouges-Michel C, Bonnal C, Dromer F, Bretagne S,
Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest
in nine different hospital laboratories. Clin Microbiol Infect, 2010. 16(7):863-9.
19. Dannaoui E, S.P., Slany M, Loeffler J, Jorde AT, Cuenca-Estrella M, Hauser PM, Shrief R, Huerre M, Freiberger T,
Gaustad P, Rodriguez-Tudela JL, Bille J, Denning DW, Bretagne S, Lortholary O, Molecular detection and
identification of zygomycetes species from paraffin-embedded tissues in a murine model of disseminated
zygomycosis: a collaborative European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal
Infection Study Group (EFISG) evaluation. Journal Clinical Microbiology, 2010. 48(6):2043-2046.
20. Even C, B.-G.S., Hicheri Y, Pautas C, Botterel F, Maury S, Cabanne L, Bretagne S, Cordonnier C, Impact of invasive
fungal disease on the chemotherapy schedule and event-free survival in acute leukemia patients who survived to
fungal disease. A case-control study. Haematologica, 2010: p. haematol.2010.030825.
21. Khoufache K, Cabaret O, Farrugia C, Rivollet D, Alliot A, Allaire E, Cordonnier C, Bretagne S, Botterel F, Primary in
vitro culture of porcine tracheal epithelial cells in an air-liquid interface as a model to study airway epithelium and
Aspergillus fumigatus interactions. Medical Mycology, 2010. 48:1049-1055.
22. Thierry S, Wang DY, Arné P, Deville M, De Bruin B, Nieguitsila A, Pourcel C, Laroucau K, Chermette R, Huang WY,
Botterel F, Guillot J. Multiple-locus variable-number tandem repeat analysis for molecular typing of Aspergillus
fumigatus. BMC Microbiology, 2010. 10(1):315.
23. White PL, Bretagne S, Klingspor L, Melchers WJG, McCulloch E, Schulz B, Finnstrom N, Mengoli C, Barnes RA, Donnelly
JP, Loeffler J, on behalf of the European Aspergillus PCR Initiative, Aspergillus PCR: one step closer to
standardization. Journal of Clinical Microbiology, 2010. 48(4):1231-1240.
24. White PL, P.M., Loeffler J, Melchers W, Klingspor L, Bretagne S, McCulloch E, Cuenca-Estrella M, Finnstrom N,
Donnelly JP, Barnes RA, on behalf of the European Aspergillus PCR Initiative, Critical stages of extracting DNA from
Aspergillus fumigatus in whole-blood specimens. Journal of Clinical Microbiology, 2010. 48(10):3753-3755.
2011
25. Alanio A, S.E., Liance M, Farrugia C, Foulet F, Botterel F, Hicheri Y, Cordonnier C, Costa JM, Bretagne S, Low
prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological
malignancies. Journal of Antimicrobial Chemotherapy, 2011. 66(2):371-374.
26. Bellanger AP, M.L., Rognon B, Roussel S, Botterel F, Bretagne S, Reboux G, Variable beta-glucans production by
different states of Eurotium amstelodami explains differences in inflammatory responses in airway cells. APMIS,
2011. 49(6):605-610.
27. Borba MR, S.E., Correa AM, Spanamberg A, de Souza Leal J, Soares MP, Guillot J, Driemeier D, Ferreiro L,
Immunohistochemical and ultra-structural detection of Pneumocystis in wild boars (Sus scrofa) co-infected with
porcine circovirus type 2 (PCV2) in Southern Brazil. Medical Mycology, 2011. 49(2):172-175.
28. Cabaret O, Puel O., Botterel F, Pean M, Bretagne S, Delaforge M, Contribution of uniformly (13) C-enriched
sterigmatocystin to the study of its pulmonary metabolism. Rapid Commun Mass Spectrom, 2011. 25(19): p. 27042710.
29. Cabaret O, T.G., Abermil N, Alsamad IA, Botterel F, Costa JM, Papon JF, Bretagne S, Degradation of fungal DNA in
formalin-fixed paraffin-embedded sinus fungal balls hampers reliable sequence-based identification of fungi. Medical
Mycology, 2011. 49(3): p. 329-332.
30. Nieguitsila A, Arné P, Durand B, Deville M, Benoit-Valiergue H, Chermette R, Cottenot-Latouche S, Guillot J, Relative
efficiencies of two air sampling methods and three culture conditions for the assessment of airborne culturable fungi
in a poultry farmhouse in France. Environmental Research, 2011. 111(2):248-253.
2012
31. Akbar H, P.C., Aliouat-Denis CM, Derouiche S, Taylor ML, Pottier M, Carreto-Binaghi LH, González-González AE,
Courpon A, Barriel V, Guillot J, Chabé M, Suarez-Alvarez RO, Aliouat el M, Dei-Cas E, Demanche C, Characterizing
pneumocystis in the lungs of bats: understanding pneumocystis evolution and the spread of Pneumocystis organisms
in mammal populations. Applied Environmental Microbiology, 2012. 78(22):8122-8136.
32. Botterel F, C.O., Foulet F, Cordonnier C, Costa JM, Bretagne S, Clinical significance of quantifying Pneumocystis
jirovecii DNA by using real-time PCR in bronchoalveolar lavage fluid from immunocompromised patients. Journal of
Clinical Microbiology, 2012. 50(2):227-231.
33. Costa JM, Botterel F, Cabaret O, Foulet F, Cordonnier C, Bretagne S, Association between circulating DNA, serum (1>3)-β-D-glucan, and pulmonary fungal burden in Pneumocystis pneumonia. Clinical Inf Dis, 2012. 55(2):5-8.
34. Wang DY, Hadj-Henni L, Thierry S, Arné P, Chermette R, Botterel F, Hadrich I, Makni F, Ayadi A, Ranque S, Huang
WY, Guillot J, Simple and highly discriminatory VNTR-based multiplex PCR for tracing sources of Aspergillus flavus
Iiolates. PLoS One, 2012. 7(9):e44204.
2013
35. Cabaret O, Puel O, Botterel F, Delaforge M, Bretagne S. Metabolic detoxication pathways for methoxysterigmatocystin in primary tracheal epithelial cells. Xenobiotica. 2013 in press.
36. Thierry S, Durand B, Melloul E, Tafani JP, Wang DY, Deville M, Cordonnier N, Chermette R, Guillot J, Arné P.
Assessment of Aspergillus fumigatus pathogenicity in aerosol-challenged chickens (Gallus gallus) belonging to two
lineages. Comp Immunol Microbiol Infect Dis. 2013 in press.
Clinical cases
2008
1. Belluco S, T.J., Guillot J, Krockenberger MB, Wyers M, Blot S, Colle MA, Spinal cryptococcoma in an
immunocompetent cat. Journal of Comparative Pathology 2008. 139:246-251.
2. Faibis F, Sapir D, Luis D, Laigneau P, Lepoutre A, Pospisil F, Borgey F, Demachy MC, Botterel F. Severe group a
Streptococcus infection after thyroidectomy: report of three cases and review. Surg Infect (Larchmt). 2008;9(5):52931.
3. Huet E, Hadji C, Hulin A, Botterel F, Bretagne S, Lévy Y. Therapeutic monitoring is necessary for the association
itraconazole and efavirenz in a patient with AIDS and disseminated histoplasmosis. AIDS, 2008. 12;22(14).
4. Matignon M, Botterel F, Audard V, Dunogue B, Dahan K, Lang P, Bretagne S, Grimbert P. Outcome of renal
transplantation in eight patients with Candida sp. contamination of preservation fluid. Am J Transplant, 2008.
8(3):697-700.
2009
5. Albano L, Bretagne S, Mamzer-Bruneel MF, Kacso I, Desnos-Ollivier M, Guerrini P, Le Luong T, Cassuto E, Dromer F,
Lortholary O, Evidence that graft-site candidiasis after kidney transplantation is acquired during organ recovery: a
multicenter study in France. Clinical Infectious Diseases, 2009. 48(2):194-202.
6. Hugnet C, M.B., Dally C, Guillot J, Osteomyelitis and discospondylitis due to Scedosporium apiospermum in a dog.
Journal of Veterinary Diagnostic Investigation, 2009. 21:120-123.
7. Mourier O, DP, Lambert V, Bretagne S, Maurage C, Branchereau S, Bernard O, Jacquemin E, Aspergillus fumigatus
endocarditis in a pediatric liver transplant recipient: favorable outcome without cardiac surgery. Pediatric
Transplantation 2009. 13(5):636-640.
2010
8.
Bellanger AP, R.G., Botterel F, Candido C, Roussel S, Rognon B, Dalphin JC, Bretagne S, Millon L, New evidence of
the involvement of Lichtheimia corymbifera in farmer's lung disease. Medical Mycology, 2010. 48(7):981-987.
9. Kazan E, M.J., Herbrecht R, Weisser M, Gachot B, Vekhoff A, Caillot D, Raffoux E, Fagot T, Reman O, Isnard F,
Thiebaut A, Bretagne S, Cordonnier C, A retrospective series of gut aspergillosis in haematology patients. Clinical
Microbiology Infection, 2010. 15.
10. Leperlier D, VR, Laloy E, Debeaupuits J, De Fornel Thibaud P, Crespeau F, Guillot J, Fungal rhinosinusitis caused by
Scedosporium apiospermum in a cat. Journal of Feline Medicine & Surgery, 2010. 12:967-971.
2011
11. Alanio A, R.S., Penso-Assathiany D, Foulet F, Botterel F, Microsporum praecox: molecular identification of a new case
and review of the literature. Mycopathologia, 2011. 171(1):61-65.
12. Cafarchia CL, Figueredo LA, da Silva Machado ML, Ferreiro L, Guillot J, Boekhout T, Otranto D, Physiological and
molecular characterization of atypical lipid-dependent Malassezia yeasts from a dog with skin lesions: adaptation to
a new host? Medical Mycology, 2011. 49(4):365-374.
13. Machado ML, F.L., Ferreira RR, Corbellini LG, Deville M, Berthelemy M, Guillot J., Malassezia dermatitis in dogs in
Brazil: diagnosis, evaluation of clinical signs and molecular identification. Veterinary Dermatology, 2011. 22(1):46-52.
14. Machmachi H, G.N., Develoux M, Bretagne S, Bazeli A, Amsellem D, Desnos-Olivier M, Poirat JB, Black grain
mycetoma caused by Laeptosphaeria tompkinsii. Medical Mycology, 2011. 49(2):186-189.
15. Pin D, Vidémont E, Derian-Autier D, Guillot J, Plouzeau E, First description of onychomycosis caused by
Chrysosporium keratinophilum in captive Bennett’s wallabies. Journal of Wildlife Diseases, 2011. 42:156-159.
2012
16. Saliba F, DV, Ichaï P, Kassis N, Botterel F, Mihaila L, Azoulay D, Adam R, Castaing D, Bretagne S, Samuel D, Outcomes
associated with amphotericin B lipid complex (ABLC) prophylaxis in high-risk liver transplant patients. Medical
Mycology, 2012, 17.
17. Sitterlé E, FE, Foulet F, Cabaret O, Cremer G, Guillot J, Delhaes L, Botterel F, Trichophyton bullosum: a new
zoonotic dermatophyte species. Medical Mycology, 2012. 50(3):305-309.
18. Toussain G, Botterel F, Abd Alsamad I, Zerah-Lancner F, Prulière-scabasse, Coste A, Papon JF, Sinus fungal balls:
characteristics and management in patients with host factors for invasive infection. Rhinology, 2012. 50(3):269-276.
2013
19. Crosaz O, Legras A, Vilaplana-Grosso F, Debeaupuits J, Chermette R, Hubert B, Guillot J, Generalized dermatitis
associated with Malassezia overgrowth in cats: a report of six cases in France. Medical Mycology Case Reports, 2013.
Reviews
2008
1. Aliouat-Denis CM, C.M., Demanche C, Aliouat E, Viscogliosi E, Guillot J, Delhaes L, Dei-Cas E, Pneumocystis species:
coevolution and pathogenic power. Infection Genetics and Evolution 2008. 8:708-726.
2. Guillot J, Hadina S, Guého E, The genus Malassezia: old facts and new concepts. Parassitologia 2008. 50:77-79.
3. Chermette R, Ferreiro L, Guillot J, Dermatophytoses in animals. Mycopathologia 2008. 166:385-405.
4. Derouiche S, DM, Taylor ML, Akbar H, Guillot J, Carreto-Binaghi LE, Pottier M, Aliouat EM, Aliouat-Denis CM, Dei-Cas
E, Demanche C, Pneumocystis diversity as a phylogeographic tool. Memorias do Instituto Oswaldo Cruz 2009. 104:112117.
2009
5. Nègre A, Bensignor E, Guillot J, Evidence-based veterinary dermatology: a systematic review of interventions for
Malassezia dermatitis in dogs. Veterinary Dermatology 2009. 20:1-12.
2010
6. Bretagne S. Advances and Prospects for Molecular Diagnostics of Fungal Infections. Curr Infect Dis Rep 2010, 12:43–
436.
2011
7. Arné P, Thierry S, Wang D, Deville M, Le Loc'h G, Desoutter A, Féménia F, Nieguitsila A, Huang W, Chermette R,
Guillot J, Aspergillus fumigatus in Poultry. International Journal of Microbiology 2011. 746356.
8. Bretagne S, Primary diagnostic approaches of invasive aspergillosis - molecular testing. Medical Mycology, 2011. 49
suppl. 1(0):S48-53.
2013
9. Saliba F, Delvart V, Ichaï P, Kassis N, Botterel F, Mihaila L, Azoulay D, Adam R, Castaing D, Bretagne S, Samuel D.
Fungal infections after liver transplantation: outcomes and risk factors revisited in the MELD era. Clinical
Transplantation 2013 May 9.
10. Saliba F, Delvart V, Ichaï P, Kassis N, Botterel F, Mihaila L, Azoulay D, Adam R, Castaing D, Bretagne S, Samuel D.
Outcomes associated with amphotericin B lipid complex (ABLC) prophylaxis in high-risk liver transplant patients.
Medical Mycology 2013. 51(2):155-163.
11. Seyedmousavi S, Guillot J, de Hoog GS, Phaeohyphomycoses, emerging opportunistic diseases in animals. Clinical
Microbiology Reviews 2013. 26(1):19-35.
12. Seyedmousavi S, Guillot J, Arné P, Melchers WJG, Mouton JW, Verweij PE, Aspergillosis, a global animal health
concern in paralell with human diseases. Clinical Microbiology Reviews (in press)
Publications of Eric Dannaoui (who joined our group in September 2012)
N=30
Research articles
1. Dannaoui E, Lortholary O, Raoux D, Bougnoux ME, Galeazzi G, Lawrence C, Moissenet D, Poilane I, Hoinard D, Dromer
F, the YEASTS Group. Comparative in vitro activity of caspofungin and micafungin, determined using the method of
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
the European Committee on Antimicrobial Susceptibility Testing (EUCAST), against yeasts isolates obtained in France
in 2005-2006. Antimicrobial Agents and Chemotherapy, 2008, 52, 778-781 (IF: 4,84)
Partida-Martinez LP, Bandemer S, Rüchel R, Dannaoui E, Hertweck C. Lack of evidence of endosymbiotic toxinproducing in clinical Rhizopus isolates. Mycoses, 2008, 51, 266-269 (IF: 2,25)
Desnos-Ollivier M, Bretagne S, Raoux D, Hoinard D, Dromer F, Dannaoui E. Mutations in the fks1 gene in Candida
albicans, C. tropicalis and C. krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the
method of the European Committee on Antibiotic Susceptibility Testing. Antimicrobial Agents and Chemotherapy,
2008. 52, 3092-8 (IF: 4,84)
Desnos-Ollivier M, Dromer F, Dannaoui E. Detection of caspofungin resistance in Candida spp. by Etest. Journal of
Clinical Microbiology, 2008. 46, 2389-92 (IF: 4,15)
Berge M, Guillemain R, Boussaud V, Pham MH, Chevalier P, Batisse A, Amrein C, Dannaoui E, Loriot MA, Lillo-Le Louet
A, Billaud EM. Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients. Transplant
Infectious Diseases. 2009, 11, 211-219 (IF: 2,22)
Bitar D, Van Cauteren D, Lanternier F, Dannaoui E, Che D, Dromer F, Desenclos JC, Lortholary O. Increasing incidence
of zygomycosis (mucormycosis), France, 1997-2006. Emerging Infectious Diseases, 2009, 15, 1395-401 (IF: 6,17)
Dannaoui E, Schwarz P, Lortholary O. In vitro interactions between antifungals and immunosuppressive drugs against
zygomycetes. Antimicrobial Agents and Chemotherapy, 2009, 53, 3549-51 (IF: 4,84)
Garcia-Hermoso D, Hoinard D, Gantier JC, Grenouillet F, Dromer F, Dannaoui E. Molecular and phenotypic evaluation
of Lichtheimia corymbifera (formerly Absidia corymbifera) complex isolates associated with human mucormycosis:
rehabilitation of L. ramosa. Journal of Clinical Microbiology, 2009, 47, 3862-70 (IF: 4,15)
Dannaoui E, Paugam A, Develoux M, Chochillon C, Matheron J, Datry A, Bouges-Michel C, Bonnal C, Dromer F,
Bretagne S. Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory
and the Etest in nine different hospital laboratories. Clinical Microbiology and Infection, 2010, 16, 863-9 (IF: 4,54)
Dannaoui E, Schwarz P, Slany M, Loeffler J, Jorde AT, Cuenca-Estrella M, Hauser PM, Shrief R, Huerre M, Freiberger
T, Gaustad P, Rodriguez-Tudela JL, Bille J, Denning DW, Bretagne S, Lortholary O. Molecular detection and
identification of zygomycetes species from paraffin-embedded tissues in a murine model of disseminated
zygomycosis: a collaborative European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal
Infection Study Group (EFISG) evaluation. Journal of Clinical Microbiology, 2010, 48, 2043-6 (IF: 4,15)
Magne D, Angoulvant A, Botterel F, Bouges-Michel C, Bougnoux ME, Bouree P, Chochillon C, Cornet M, Dannaoui E,
Fekkar A, Galeazzi G, Yera H, Sarfati C, Roux P. Pneumocystosis: a network survey in the Paris area 2003-2008.
European Journal of Clinical Microbiology and Infectious Diseases, 2011, 30, 673-675 (IF: 2,86)
Planche V, Ducroz S, Alanio A, Bougnoux ME, Lortholary O, Dannaoui E. In vitro combination of anidulafungin and
voriconazole against intrinsically azole susceptible and resistant Aspergillus spp. Antimicrobial Agents and
Chemotherapy, 2012, 56, 4500-4503 (IF: 4,84)
Dannaoui E, Desnos-Ollivier M, Garcia-Hermoso D, Grenouillet F, Cassaing S, Baixench MT, Bretagne S, Dromer F,
Lortholary O, and the French Mycoses Study Group. Candida spp. with acquired echinocandin-resistance, France,
2004-2010. Emerging Infectious Diseases, 2012, 18, 86-90 (IF: 6,17)
Vitale RG, de Hoog GS, Schwarz P, Dannaoui E, Deng S, Machouart M, Voigt K, van de Sande WWJ, Dolatabadi S, Meis
JF, Walther G. Antifungal susceptibility and phylogeny of opportunistic members of the order Mucorales. Journal of
Clinical Microbiology, 2012, 50, 66-75 (IF: 4,15)
Lanternier F, Dannaoui E, Morizot G, Elie C, Garcia-Hermoso D, Huerre M, Bitar D, Dromer F, Lortholary O. and the
French Mycosis Study Group. A global analysis of mucormycosis in France: the “RetroZygo study” (2005-2007). Clinical
Infectious Diseases, 2012, 54 Suppl 1, S35-S43 (IF: 9,15)
Xhaard A, Lanternier F, Dannaoui E, Bergeron A, Lacroix C, Herbrecht R, Legrand F, Mohty M, Michallet M,
Cordonnier-Carlet C, Isnard F, Guyotat D, Couderc LJ, Socié G, Lortholary O, Ribaud P. Zygomycosis after allogeneic
hematopoietic stem cell transplantation: a french multicenter cohort study (2003-2008). Clinical Microbiology and
Infection, 2012, 18, E396-E400 (IF: 4,54)
Clinical cases
17. Blanchet D, Dannaoui E, Fior A, Huber F, Couppié P, Salhab A, Hoinard D, Aznar C. Saksenaea vasiformis infection,
French Guiana Emerging Infectious Diseases, 2008, 14, 342-344 (IF: 6,17)
18. Soummer A, Mathonnet A, Scatton O, Massault PP, Paugam A, Lemiale V, Mira JP, Dannaoui E, Cariou A, Lortholary O.
Failure of deferasirox, an iron chelator agent, combined with antifungals in a case of severe zygomycosis.
Antimicrobial Agents and Chemotherapy, 2008. 52, 1585-6 (IF: 4,84)
19. Lechevalier P, Garcia-Hermoso D, Carol A, Bonacorsi S, Ferkdadji L, Fitoussi F, Lortholary O, Bourrillon A, Faye A,
Dannaoui E, Angoulvant F. Molecular diagnosis of Saksenaea vasiformis cutaneous infection after scorpion sting in an
immunocompetent adolescent. Journal of Clinical Microbiology, 2008. 46, 3169-3172 (IF: 4,15)
20. Almaslamani MS, Taj-Aldeen SJ, Garcia-Hermoso D, Dannaoui E, Al Soub H, Alkhal A. An increasing trend of cutaneous
zygomycosis caused by Mycocladus corymbifer (formerly Absidia corymbifera): report of two cases and review of
primary cutaneous Mycocladus infections Medical Mycology, 2009, 47, 532-538 (IF: 2,46)
21. Gaillard Le Roux B, Mechinaud F, Gay-Andrieu F, Lortholary O, Dannaoui E, Hoinard D, Corradini N. Successful triple
combination therapy of disseminated Absidia corymbifera infection in an adolescent with osteosarcoma. Journal of
Pediatric Hematology/Oncology, 2010, 32, 131-3 (IF: 1,16)
22. Giraud S, Pihet M, Razafimandimby B, Carrere J, Degand N, Mely L, Favennec L, Dannaoui E, Bouchara JP, Calenda A.
Geosmithia argillacea: an emerging pathogen in patients with cystic fibrosis. Journal of Clinical Microbiology, 2010,
48, 2381-6 (IF: 4,15)
Reference documents (co-author as member of the EUCAST AFST Committee)
23. Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial
Susceptibility Testing (EUCAST), Rodriguez-Tudela JL, Arendrup MC, Barchiesi F, Bille J, Chryssanthou E, CuencaEstrella M, Dannaoui E, Denning DW, Donnelly JP, Dromer F, Fegeler W, Lass-Florl C, Moore C, Richardson M, Sandven
P, Velegraki A, Verweij P. EUCAST Definitive Document EDef 7.1: method for the determination of broth dilution MICs
of antifungal agents for fermentative yeasts. Clinical Microbiology and Infection. 2008. 14, 398-405 (IF: 4,54)
24. Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial
Susceptibility Testing (EUCAST), Rodriguez-Tudela JL, Donnelly JP, Arendrup MC, Arikan S, Barchiesi F, Bille J,
Chryssanthou E, Cuenca-Estrella M, Dannaoui E, Denning DW, Fegeler W, Gaustad P, Lass-Florl C, Moore C, Richardson
M, Schmalreck A, Stenderup J, Velegraki A, Verweij P. EUCAST Technical Note on the method for the determination
of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds Clinical
Microbiology and Infection, 2008, 14, 982-984 (IF: 4,54)
25. Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial
Susceptibility Testing (EUCAST), Rodriguez-Tudela JL, Donnelly JP, Arendrup MC, Arikan S, Barchiesi F, Bille J,
Chryssanthou E, Cuenca-Estrella M, Dannaoui E, Denning DW, Fegeler W, Gaustad P, Klimko N, Lass-Florl C, Moore C,
Richardson M, Schmalreck A, Stenderup J, Velegraki A, Verweij P. EUCAST Technical Note on fluconazole. Clinical
Microbiology and Infection, 2008, 14, 193-195 (IF: 4,54)
26. Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial
Susceptibility Testing (EUCAST), Rodriguez-Tudela JL, Donnelly JP, Arendrup MC, Arikan S, Barchiesi F, Bille J,
Chryssanthou E, Cuenca-Estrella M, Dannaoui E, Denning DW, Fegeler W, Gaustad P, Lass-Florl C, Moore C, Richardson
M, Schmalreck A, Stenderup J, Velegraki A, Verweij P. EUCAST Technical Note on voriconazole. Clinical Microbiology
and Infection, 2008, 14, 985-987 (IF: 4,54)
Reviews
27. Balajee SA, Borman AM, Brandt ME, Cano J, Cuenca-Estrella M, Dannaoui E, Guarro J, Haase G, Kibbler CC, Meyer W,
O'Donnell K, Petti CA, Rodriguez-Tudela JL, Sutton D, Velegraki A, Wickes BL. Sequence-based identification of
Aspergillus, Fusarium and mucorales species in the clinical mycology laboratory: where are we and where should we
go from here? Journal of Clinical Microbiology, 2009, 47, 877-84 (IF: 4,15)
28. Dannaoui E. Molecular tools for identification of Zygomycetes and diagnosis of zygomycosis. Clinical Microbiology and
Infection, 2009, 15 (Suppl. 5), 66-70 (IF: 4,54)
29. Arendrup MC, Kibbler C, Dannaoui E, Ruhnke M, Claus Peter Heussel CP, Bille J. ECIL-3 Classical diagnostic
procedures for the diagnosis of invasive fungal diseases in patients with leukemia. Bone Marrow Transplantation,
2012, 47, 1030-1045 (IF: 3,75)
30. Rammaert B, Lanternier F, Zahar JR, Dannaoui E, Bougnoux ME, Lecuit M, Lortholary O. Healthcare-associated
zygomycosis. Clinical Infectious Diseases, 2012, 54 Suppl 1, S44-S54 (IF: 9,15)
Invited Conferences
N=39
2008
1. Arné P GJ. Aspergillosis in wild birds, XII International Congress of Mycology (IUMS). Istanbul, Turquie, 2008.
2. Bretagne S. Aspergilloses Invasives : les outils diagnostiques, Colloque Experts Praticiens Pfizer. Paris, 2008.
3. Bretagne S. Diagnosis and typing of Aspergillus spp, IMMEM. Zakopane, Pologne, 2008.
4. Bretagne S. The epidemiologic outbreak investigation – factors influencing interpretation of subtyping data, IUMS, XII
International Congress of Mycology. Istanbul, Turquie, 2008.
5. Bretagne S. Et dans le pipe-line des antifongiques? , Réunion Interdisciplinaire de Chimiothérapie Anti-Infectieuse.
Paris, 2008.
6. Bretagne S. Résistance croisée: effet classe “mythe ou réalité?", Actualités et Conséquences Thérapeutiques. Paris,
2008.
7. Bretagne S. Signalement des Infections fongiques, Journées CCLIN Est. Dijon, 2008;20 mai 2008.
8. Guillot J. The genetic diversity of fungal pathogens from domestic and wild animals., 4th Croatian Congress of
Microbiology. Zadar, Croatie, 2008.
9. Guillot J. Malassezia yeasts: old facts and new concepts, Società Italiana di Parassitologia (SoIPa). Pise, Italie, 2008.
10. Guillot J DC, Dei-Cas E,. Pneumocystis fungi and mammals: a unique model of parallel history, Dutch National
Academy 200 year anniversary symposium. Amsterdam, Pays-Bas, 2008.
11. Guillot J DC, Michaux J, Dei-Cas E,. Co-evolution between fungi and animal populations, XII International Congress of
Mycology (IUMS). Istanbul, Turquie, 2008.
2009
12. Guillot J DC, Dei-Cas E,. Pneumocystis host-specificity and co-evolution, Pneumocystis Discovery Centennial
Anniversary.Bruxelles, Belgique, 2009.
13. Guillot J DC, Dei-Cas E,. Pneumocystis spp: proxies for mammalian host phylogeny and ecology, 17th Congress of the
International Society for Human and Animal Mycology (ISHAM). Tokyo, Japon, 2009.
14. Bretagne S. Actualités thérapeutiques des aspergilloses, 37ème congrès de la Société de Réanimation de Langue
Française. Paris, 2009.
15. Bretagne S. Le diagnostic moléculaire des infections fongiques, Congrès de la Société Française de Mycologie
Médicale. Poitiers, 2009.
16. Bretagne S. Manifestations cliniques et diagnotic des aspergilloses, 19ème congrès de la Société Tunisienne de
Pathologie Infectieuse. Tunis, Tunisie, 2009.
17. Bretagne S. Outils diagnostiques des infections fongiques invasives, 37ème congrès de la Société de Réanimation de
Langue Française. Paris, 2009.
18. Bretagne S. Résistance des Aspergillus aux azolés: mythe ou réalité ? , 29ème RICAI. Paris, 2009.
19. Bretagne S. Role of molecular methods in diagnosis, 4th Trends in Medical Mycology. Athènes, Grèce, 2009.
20. Guillot J HC, Chermette R, . Malassezia pachydermatis on the skin of dogs: distribution and population structure in
the genomic era, 17th Congress of the International Society for Human and Animal Mycology (ISHAM). Tokyo, Japon,
2009.
21. Guillot J HC, Chermette R,. Malassezia yeasts in cats, 15ième Eurocongrès FECAVA. Lille, 2009.
22. Guillot J NA, Arné P,. Bio-aérosols fongiques en élevage ; méthodes d’analyse et impact sanitaire, MicrobAero «
Microbiologie des aérosols ». Narbonne, 2009.
23. Guillot J TS, Arné P,. Avian aspergilloses: from experimental models to field investigations, 17th Congress of the
International Society for Human and Animal Mycology (ISHAM). Tokyo, Japon, 2009.
24. Guillot J. Malassezia dermatitis in animals, 17th Congress of the International Society for Human and Animal
Mycology (ISHAM). Tokyo, Japon, 2009.
2010
25. Bretagne S. Diagnostic biologique des infections fongiques invasives, Séminaire sur les infections en oncohématologie. Rabat, Maroc, 2010.
26. Bretagne S. ECIL3 guidelines update: diagnosis, Symposium Pfizer, 36th EBMT meeting. Vienne, Autriche, 2010.
27. Bretagne S. Is molecular subtyping a clinical tool?, 20th ECCMID (European Congress of Clinical and Infectious
Diseases (ECCMID), . Vienne, Autriche, 2010.
28. Bretagne S. La mycologie dans l’aspergillose, IXème journée de Pathologie Thoracique de l’hôpital Percy. Paris, 2010.
29. Bretagne S. Les différentes classes d’antifongiques: mode d’action, spectre, effets secondaires, Séminaire sur les
infections en onco-hématologie. Rabat, Maroc, 2010.
30. Bretagne S. Outils de typage moléculaire pour l’investigation d’épidémies d’infections à Candida, 30ème RICAI. Paris,
2010.
31. Bretagne S. Primary diagnostic approaches - molecular testing, 4th Advances Against Aspergillosis. Rome, Italie,
2010.
32. Bretagne S. Update on molecular diagnostic tests for yeast and mould infections, European Society of Clinical
Microbiology and Infectious Diseases (ESCMID) Conference. Rome, Italie, 2010.
33. Guillot J. Emerging or newly recognized fungal diseases in cats, Merial pre-congress ESFM. Amsterdam, Pays-Bas,
2010.
2011
34. Guillot J. Malassezia spp. a group of basidiomycetous yeasts living on the skin, Annual congress of the Croatian
Society of Microbiology. Primosten, Croatie, 2011.
35. Guillot J AP, Chermette R,. Impact de l’utilisation des antifongiques dans les élevages aviaires, Réunion de la Société
Française de Mycologie Médicale (SFMM). Paris, 2011.
2013
36. Guillot J CR. Les antifongiques d’usage vétérinaire, Consortium Antiparasitaire. Lille, 2013.
37. Guillot J DC, Dei-Cas E,. Les Pneumocystis et les mammifères : une longue histoire commune, Réunion de la Société
Française de Microbiologie (SFM). Lille, 2013.
38. Guillot J EMA, Demanche C, Dei-Cas E,. What's new about the genus Pneumocystis? from taxonomy to biology, 23rd
Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Berlin, Allemagne, 2013.
39. Guillot J. L’aérocontamination fongique dans les bâtiments d’élevage, Contaminexpo. Paris, 2013.
Oral presentations at international congresses
N=18
2008
1. Grenouillet F BF, Ranque S, Dannaoui E, Crouzet J, Delhaes L,. Scedosporium prolificans: an emerging pathogen in
France? Workshop Scedosporium in ISHAM group, Angers, 2008.
2. Guillot J DM, Gantois N, Aliouat C-M, Dei-Cas E, Kauffmann-Lacroix C, Fréalle E, Delhaes L,. Genetic diversity of
animal and human Trichophyton mentagrophytes isolates: clinical and epidemiological involvements. 6th World
Congress of Veterinary Dermatology (WCVD), Hong Kong, 2008.
2009
3. Deplazes P FM, Guillot J, Genchi C, Miro G, van Knapen F, Thamsborg SM, Joachim A, Schnieder T, Duncan J,.
ESCCAP: the role of an ingo (International Non-Governmental Organisation) in contributing to the understanding and
control of companion animal parasites in a changing landscape. 22th International Conference of the World
Association for the Advancement of Veterinary Parasitology (WAAVP), Calgary, Canada, 2009.
2011
4. Bex V BS, Nieguitsila A, Moularat S, Bergeron V, Choukri F, Guillot J, Derouin F, Squinazi F,. Measurement of indoor
mould exposure: development of a global approach associating quantitative and qualitative tools from long duration
air samplings. Indoor Air congress, Cincinnati, USA, 2011.
5. Botterel F SF, Rivett, Cabaret O, Husson MO, Rogers G, Wallaert B, Delhaes L, Bruce K,. Polymicrobial infections of
the cystic fibrosis lung: what can we learn from combining culture and molecular approaches? . 2nd Meeting
of the ECMM/ISHAM Working Group: Fungal respiratory infections in Cystic Fibrosis, Angers, 2011.
6. Demanche C DM, Aliouat-Denis CM, Chabé M, Standaert-Vitse A, Pottier M, Aliouat EM, Guillot J, Dei-Cas E,.
Pneumocystis organisms: atypical fungi that could be used to gain insight into the phylogeny and phylogeography of
mammalian hosts. Congress of the Wildlife Disease Association (WDA), Canada, 2011.
2012
7. Barral S BV, Moularat S, Choukri F, Bergeron V, Nieguitsila A, Guillot J, Derouin F, Squinazi F,. Measurement of
exposure to indoor molds – comprehensive approach combining quantitative and qualitative tools from long-term air
sampling. 5th European Symposium on Aerobiology (ESA), Cracovie, Pologne, 2012.
8. Botterel F FF, Sitterlé E, Fréalle E, Cabaret O, Cremer G, Chermette R, Delhaes L, Guillot J,. Microsporum praecox
and Trichophyton bullosum, two Equid-related dermatophytes that may be zoonotic. 18th Congress of the
International Society for Human and Animal Mycology (ISHAM), Berlin, Allemagne, 2012.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
Crosaz O LA, Vilaplana-Grosso F, Debeaupuits J, Hubert B, Marignac G, Guillot J,. Malassezia pachydermatis
overgrowth in 6 cats with generalized dermatitis. 7th World Congress of Veterinary Dermatology (WCVD), Vancouver,
Canada, 2012.
Crosaz O LA, Hubert B, Desquilbet L, Chermette R, Guillot J,. Malassezia yeasts in cats: from normal cutaneous
carriage to pathogenic overgrowth. 18th Congress of the International Society for Human and Animal Mycology
(ISHAM), Berlin, Allemagne, 2012.
Legras A CO, Petit E, Hubert B, Desquilbet L, Chermette R, Guillot J,. Cutaneous carriage of Malassezia species in
healthy and diseased cats in Paris area. 7th World Congress of Veterinary Dermatology (WCVD), Vancouver, Canada,
2012.
Shimizu N HM, Pignon C, Guillot J,. Simple and highly discriminatory VNTR-based multiplex PCR for the typing of
Aspergillus flavus isolates from different geographic origins and different hosts. X International Congress on Wild and
Exotic Animals, Maisons-Alfort, 2012.
Thierry S WD, Hadj-Henni L, Pourcel C, Hadrich I, Makni F, Ayadi A, Ranque S, Botterel F, Huang WY, Arné P,
Chermette R, Guillot J,. Simple and highly discriminatory VNTR-based methods for the typing of Aspergillus fumigatus
and A. flavus isolates from different geographic origins and different hosts. 18th Congress of the International Society
for Human and Animal Mycology (ISHAM), Berlin, Allemagne, 2012.
Wang DY AP, Thierry S, Chermette R, Huang WY, Guillot J,. Detection of azole-resistant Aspergillus fumigatus isolates
in avian farms from Guangxi Province, China. 2nd Annual International Symposium of Mycology (ISM), Guangzhou,
Chine, 2012.
Wang DY GM, Arné P, Thierry S, Seguin D, Chermette R, Huang WY, Botterel F, Guillot J,. Azole-resistance in
Aspergillus fumigatus: a side effect of fungal drugs use in avian farms? 18th Congress of the International Society for
Human and Animal Mycology (ISHAM), Berlin, Allemagne, 2012.
Wang DY GM, Arné P, Thierry S, Seguin D, Chermette R, Huang WY, Botterel F, Guillot J,. May avian farms constitute
a source of azole-resistant Aspergillus fumigatus isolates? . 5th Advances Against Aspergillosis (AAA), Istanbul,
Turquie, 2012.
Wang DY TS, Arné P, Chermette R, Huang WY, Guillot J,. Genetic diversity of Aspergillus fumigatus and Aspergillus
flavus from avian farms in Guangxi Province, China. 2nd Annual International Symposium of Mycology (ISM),
Guangzhou, Chine, 2012.
Wang DY ZL, Thierry S, Arné P, Chermette R, Pourcel C, Botterel F, Hadrich I, Ayadi A, Ranque S, Huang WY, Guillot
J,. Simple and highly discriminatory VNTR-based multiplex PCR for the typing of Aspergillus flavus isolates from
different geographic origins and different hosts. 5th Advances Against Aspergillosis (AAA), Istanbul, Turquie, 2012.
Oral presentations at national congresses
N=24
2008
1. Gomes E, Corre J, Begon D, Guillot J, Besso J, Clerc B, Payen G, Rosenberg D, Torok S, Blot S, Chermette R.
Blastomycose disséminée chez un chien en provenance du Québec. Difficultés diagnostiques face à un cas
d’importation. Congrès de la Société Française de Mycologie Médicale (SFMM), 15-16 mai 2008, Tours
2. Alanio A, Romand S, Penso-Assathiany D, Farrugia C, Foulet F, Botterel F. Dermatophytie cutanée à Microsporum
praecox. A propos d’un nouveau cas. Société Française de Mycologie Médicale (SFMM) Tours 19-20 mai 2008
3. Hadina S, Deville M, Berthelemy M, Guého E, Kosalec I, Pinter L, Guillot J. Biochemical and molecular identification
of Malassezia sp. isolated from the healthy or inflamed animal external auditory canal. 4th Croatian Congress of
Microbiology, 24-27 septembre 2008, Zadar, Croatie
4. Botterel F, Foulet F, Chicira C, Farrugia C, Soria AM, Bretagne S. Analyse mycologique des liquides de conservation
d’organes : étude prospective sur 5 ans (2004 – 2008). Société Française de Mycologie Médicale (SFMM). Paris. 24-25
novembre 2008.
5. Thierry S, De Bruin B, Deville M, Arné P, Botterel F, Bretagne S, Nieguitsila A, Pourcel C, Laroucau K, Guillot J.
Etude du polymorphisme d’Aspergillus fumigatus par MLVA (Multi Locus VNTR Analysis). Congrès de la Société
Française de Mycologie Médicale (SFMM), 28-29 novembre 2008, Paris
2009
6. Hadjaje C, Hubert B, Marignac G, Guillot J, Chermette R. A propos de 3 cas de mycétomes fongiques félins. Congrès
annuel du Groupe d’Etude en Dermatologie des Animaux de Compagnie (GEDAC), 3-5 avril 2009, Reims
7. Alekseeva L, Féménia F, Huet D, Mouyna I, Guerrier D, Baeza-Squiban A, Chermette R, Guillot J, Latgé JP, Berkova N.
Cellules épithéliales : témoins passifs ou participants actifs de la défense de l’hôte ? Modèle d'épithélium respiratoire
infecté par Aspergillus fumigatus. Journées d’Animation Scientifique du Département INRA de Santé Animale, 25-28
mai 2009, Port d’Albret
8. Bellanger AP, Reboux G, Botterel F, Candida C, Roussel S, Dalphin JC, Bretagne S., Millon L. De nouveaux arguments
en faveur du rôle pathogène d’Absidia corymbifera dans la maladie du poumon de fermier. Société Française de
Mycologie Médicale (SFMM) Poitiers 18-19 juin 2009.
9. Barral S, Choukri F, Bergeron V, Bex-Capelle V, Nieguitsila A, Guillot J, Squinazi F, Derouin F. Etude de l’efficacité de
différents biocollecteurs après nébulisation d’Aspergillus niger dans une salle à ambiance contrôlée. MicrobAero
« Microbiologie des aérosols », 6-8 octobre 2009, Narbonne
10. Boudih S, Rakotonirainy M, Puel O, Delaforge M, Bretagne S. Viabilité fongique et analyse par HPLC-UV-MS de papiers
détériorés par le foxing. Programme National de Recherche sur la Connaissance et la Conservation des matériaux du
patrimoine culturel 2009. Archives Nationales de France Paris 29 septembre 2009.
11. Arné P, Thierry S, Chermette R, Guillot J. Présentation des activités de l’équipe ECOPHAM aux professionnels de la
filière avicole. JACIE (journée avicole et cunicole), 24 novembre 2009, Nantes
2010
12. Chermette R, Hadjaje C, Hubert B, Marignac G, Crosaz O, Bernex F, Garcia Hermoso-Kaiser D, Guillot J. Mycétome à
Paecilomyces lilacinus chez un chat. Congrès de la Société Française de Mycologie Médicale (SFMM), 11-13 janvier
2010, Martinique
13. Thierry S, Arné P, Deville M, Laroucau K, Chermette R, Botterel F, Bretagne S, Pourcel C, Guillot J. Une nouvelle
technique de typage moléculaire d’Aspergillus fumigatus : est-ce bien nécessaire ? Congrès commun de la Société
Française de Parasitologie et de la Société Française de Mycologie Médicale (SFP-SFMM), mai 2010, Angers
14. Paugham A, Angoulvant A, Botterel F, Chochillon C, Eloy O, Hennequin C, Lacroix C. Antifongigramme en
microplaque : utilisation multicentrique du test sensititre yeast one et comparasion avec la méthode E-test. Société
Française de Mycologie Médicale (SFMM). Paris 26-27 novembre 2010.
2011
15. Boudih S, Reboux G, Scherer E, Puel O, Roussel A, Delaforge M, Bretagne S. Moisissures et métabolites secondaires
issus de papiers peints de logements insalubres. Evaluation du risque mycotoxicologique sur des cellules respiratoires
in vitro. Journée des mycotoxines. Toulouse 18 janvier 2011.
2012
16. Cabaret O, Puel O, Botterel F, Pean M, Delaforge M, Bretagne S. Rôle des enzymes du métabolisme des xénobiotiques dans la
toxicité pulmonaire de deux mycotoxines d'Aspergillus versicolor et d'Aspergillus nidulans. Société Française de Mycologie
Médicale (SFMM). Rennes 9-11 mai 2012.
17. Cabaret O, Emirian A, Foulet F, Fihman V, Decousser JW, Botterel F. Etude rétrospective descriptive descriptive des
colonisations respiratoires associant Aspergillus fumigatus et Stenotrophomonas maltophilia ou Pseudomonas
aeruginosa entre 2007 et 2011 à l’hôpital Henri Mondor. Société Française de Mycologie Médicale (SFMM). Rennes 911 mai 2012.
18. El Anbassi S, Foulet F, Chosidow O, Botterel F. Analyse épidémiologique des cas de gale à l’hôpital Henri Mondor sur 5
ans. Société Française de Parasitologie (SFP). Rennes 9-11 mai 2012.
19. Emirian A, Cabaret O, Foulet F, Fihman V, Legrand P, Botterel F, Decousser JW. Epidémiologie des colonisations
respiratoires mixtes bactéries – champignon associant Aspergillus fumigatus et Stenotrophomonas maltophilia ou
Pseudomonas aeruginosa : etude retrospective descriptive de 2007 à 2011 dans un CHU. Société Française d’Hygiène
Hospitalière (SFHH). Lille 6-8 juin 2012.
20. Barral S, Bex V, Moularat S, Choukri F, Bergeron V, Guillot J, Durand B, Derouin F, Squinazi F. Mesure de l’exposition
aux moisissures en milieu intérieur. Congrès ESFERA, octobre 2012.
21. Botterel F, Cabaret O, Barnier JP, Stressmann F, Wallet F, Wallaert B, Decousser JW, Bruce K, Delhaes L.
Colonisation bactérienne et fongique du tractus respiratoire des patients atteints de mucoviscidose : comparaison de
la culture avec les techniques de RFLP, clonage et séquençage à haut débit. RICAI. Paris 20-21 novembre 2012.
22. Delhaes L, Chabé M, Monchy S, Salleron J, Leroy S, Prévotat A, Wallaert B, Dei-Cas E, Vicogliosi E, Botterel F.
Caractérisation de l’écosystème broncho-pulmonaire chez les patients atteints de mucoviscidose : structure et
dynamique du microbiote pulmonaire dans l’évolution clinique de la mucoviscidose. RICAI. Paris 20-21 novembre
2012.
2013
23. Botterel F, Cabaret O, Barnier JP, Stressmann F, Wallet F, Wallaert B, Decousser JW, Bruce K, Delhaes L.
Colonisation bactérienne et fongique du tractus respiratoire des patients atteints de mucoviscidose : comparaison de
la culture avec les techniques de RFLP, clonage et séquençage à haut débit. Société Française de Microbiologie (SFM)
7-8 février 2013. Lille.
24. Crosaz O, Legras A, Petit E, Hubert B, Desquilbet L, Chermette R, Guillot J. Le portage cutané de levures Malassezia
est-il plus fréquent pour certaines races de chats ou pour des animaux qui présentent des lésions cutanées ? Congrès
annuel du Groupe d’Etude en Dermatologie des Animaux de Compagnie (GEDAC), 4-6 avril 2013, Paris.
Posters at international or national congresses
N=35
2008
1. Alanio A, Liance M , Farrugia C, Foulet F, Botterel F, Pautas C , Cordonnier C, Costa JM, Bretagne S. No evidence of
azole resistant Fumigati section species strains from patients treated for hematological malignancies in the
voriconazole era. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Chicago, USA 25-28
octobre 2008. Poster M-1543
2. Botterel F, Corbel C, Foulet F, Farrugia C, Cambau E, Cordonnier C, Bretagne S. Performance of the VITEK2 Yeats®
for susceptibility testing of antifungal agents against Candida spp. and Cryptococcus neoformans. Interscience
Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Chicago, USA 25-28 octobre 2008. Poster M-1543
3. Lemo N, Guillot J, Crosaz O, Marignac G. Chronic otitis in a Bloodhound associated with mixed infection including
cytological evidence of Prototheca sp. 6th World Congress of Veterinary Dermatology (WCVD). 19-22 novembre 2008,
Hong Kong
4. Nègre A, Bensignor E, Guillot J. Evidence-based dermatology: a systematic review of treatment for Malassezia
dermatitis in dogs. 6th World Congress of Veterinary Dermatology (WCVD). 19-22 novembre 2008, Hong Kong
2009
5. Vidémont E, Pin D, Derian-Autier D, Guillot J, Plouzeau E. Onychomycosis caused by Chrysosporium keratinophilum
in Bennett’s wallabies (Macropus rufogriseus). 17th Congress of the International Society for Human and Animal
Mycology (ISHAM), 25-29 mai 2009, Tokyo, Japon
6. Guillot J, Hadjaje C, Petit T, Dally C, Deville M, Huerre M, Chermette R. Eumycetoma caused by Aspergillus
fumigatus in an alpaca (Lama pacos). 17th Congress of the International Society for Human and Animal Mycology
(ISHAM), 25-29 mai 2009, Tokyo, Japon
7. Thierry S, De Bruin B, Deville M, Arné P, Nieguitsila A, Botterel F, Bretagne S, Pourcel C, Laroucau K, Guillot J. High
resolution typing of Aspergillus fumigatus by multi locus VNTR analysis (MLVA). 17th Congress of the International
Society for Human and Animal Mycology (ISHAM), 25-29 mai 2009, Tokyo, Japon
8. Nieguitsila A, Arné P, Durand B, Haddad N, Deville M, Benoît-Valiergue H, Chermette R, Cottenot-Latouche S, Guillot
J. Comparative performance of two air samplers and mycological media for quantification of fungal
aerocontamination in a poultry facility. 17th Congress of the International Society for Human and Animal Mycology
(ISHAM), 25-29 mai 2009, Tokyo, Japon
9.
Hadjaje C, Chareyre G, Guillot J, Deville M, Hubert B, Chermette R. Urogenital and digestive infection due to
Candida albicans in a diabetic cat. 17th Congress of the International Society for Human and Animal Mycology
(ISHAM), 25-29 mai 2009, Tokyo, Japon
10. Machado M, Ferreiro L, Ferreira RR, Deville M, Berthelemy M, Bianchi SP, Guillot J. Malassezia dermatitis in dogs in
Brazil; clinical signs, diagnosis and molecular identification of causative agents. 17th Congress of the International
Society for Human and Animal Mycology (ISHAM), 25-29 mai 2009, Tokyo, Japon
11. Farrugia C, Amarsy R, Cabaret O, Foulet F, Botterel F, Bretagne S. Intérêt de l’utilisation du filtre Microcon YM 50
(Milllipore, France) dans l’amélioration des performances du test Platelia Aspergillus. Société Française de Mycologie
Médicale (SFMM). Poitiers 18-19 juin 2009
12. Poirier P, Hinzpeter A, Farrugia C, Botterel F, Fanen P, Bretagne S. Glucans induce higher IL-8 and TNF-α mRNA
production in Cystis Fibrosis Transmembrane conductance Regulator (CFTR) deficient than in non deficient
respiratory epithelial cells. Trends In Medical Mycology (TIMM), 18-21 Octobre 2009, Athènes, Grèce
13. Thierry S, Le Loch’ G, Mazzola E, Desoutter A, Huet D, Féménia F, Deville M, Chermette R, Arné P, Guillot J.
Experimental models of avian aspergillosis. Trends in Medical Mycology (TIMM), 18-21 octobre 2009, Athènes, Grèce
2010
14. Wang DY, Thierry S, Deville M, Arné P, Laroucau K, Huang WY, Guillot J. Genetic diversity of Aspergillus fumigatus
isolates from domestic birds in China (Guangxi Province). 4th Advances Against Aspergillosis, 4-6 février 2010, Rome,
Italie
15. Thierry S, Tafani JP, Deville M, Chermette R, Guillot J, Arné P. Development of an inhalational model of pulmonary
aspergillosis in chickens. 4th Advances Against Aspergillosis, 4-6 février 2010, Rome, Italie
16. Cabaret O, Puel O, Botterel F, Péan M, Delaforge M, Bretagne S. Détoxification pulmonaire de la stérigmatocystine.
Les rencontres scientifiques de l’AFSSET. Risques émergents. Paris, 11 mai 2010.
17. Boudih S, Rakotonirainy M, Puel O, Delaforge M, Bretagne S. Viabilité fongique et analyse par HPLC-UV-MS de papiers
détériorés par le foxing. Congrès de la Société Française de Mycologie Médicale (SFMM). Angers, 19-21 mai 2010
18. Cabaret O, Puel O, Botterel F, Péan M, Delaforge M, Bretagne S. Devenir de la stérigmatocystine, une mycotoxine
d'Aspergillus versicolor et d'A. nidulans, dans la cellule épithéliale pulmonaire. Société Française de Mycologie
Médicale (SFMM). Angers, 19-21 mai 2010. Poster PM 19
19. Didier E, Micaelo M, Foulet F, Cabaret O, Bretagne S, Botterel F. Performance du Platelia Aspergillus pour la
détection du galactomannane dans le lavage brochioloalvéolaire. Société Française de Mycologie Médicale (SFMM).
Angers, 19-21 mai 2010. Poster PM 17
20. Boudih S, Rakotonirainy M, Puel O, Delaforge M, Bretagne S. Le foxing est-il d’origine fongique ? Congrès de la
Société Française de Microbiologie (SFM). Marseille 2-4 juin 2010.
21. Cabaret O, Puel O, Botterel F, Péan M, Bretagne S, Delaforge M. Pulmonary metabolism of sterigmatocystin and
methoxy-sterigmatocystin studies : contribution of uniformly 13C-enriched sterigmatocystin. 17th Workshop of the
International Isotope Society - Central European Division. Bad Soden, Allemagne, 23-24 Septembre 2010. Publication
des résumés dans Journal of Labelled Compounds & Radiopharmaceuticals, 2011, 54 (5) : 287-288.
22. Cabaret O, Puel O, Botterel F, Péan M, Bretagne S, Delaforge M. Utilisation de stérigmatocystine enrichie en 13C pour
l'étude du métabolisme pulmonaire de la stérigmatocystine. 6ème congrès de la Société Française des Isotopes
Stables. Toulouse. 26-29 octobre 2010. Obtention du 2ème prix.
2012
23. Thierry S, Arné P, Pourcel C, Botterel F, Chermette R, Guillot J. Aspergillus fumigatus contamination monitoring in a
French turkey hatchery using Multiple Locus VNTR Analysis (MLVA). 5th Advances Against Aspergillosis (AAA), janvier
2012, Istanbul, Turquie
24. Wang DY, Thierry S, Arné P, Chermette R, Huang WY, Guillot J. Genetic diversity of Aspergillus fumigatus and
Aspergillus flavus from poultry farms in Southern China, Guangxi Province. 5th Advances Against Aspergillosis (AAA),
janvier 2012, Istanbul, Turquie
25. Wang DY, Gricourt M, Arné P, Thierry S, Seguin D, Chermette R, Huang WY, Botterel F, Guillot J. May avian farms
constitute a source of azole-resistant Aspergillus fumigatus isolates? 5th Advances Against Aspergillosis Conference
(AAA), Istanbul, Turquie, 26-28 Janvier 2012.
26. Wang DY, Ziani L, Thierry S, Arné P, Chermette R, Pourcel C, Botterel F, Hadrich I, Ayadi A, Ranque S, Huang W,
Guillot J. Highly discriminatory VNTR-based multiplex PCR for the typing of Aspergillus flavus isolates from different
geographic origins and different hosts. 5th Advances Against Aspergillosis (AAA) Conference, Istanbul, 26-28 Janvier
2012.
27. Botterel F, Cabaret O, Stressmann F, Rivett D, F.Wallet F, B. Wallaert B, Bruce K, Delhaes L. Bacterial and fungal
infections of the Cystic Fibrosis lung: what can we learn from combining culture, RFLP and pyrosequencing
approaches? 22nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Londres, UK, 31 mars
- 3 Avril 2012.
28. Leslé F, Foulet F, Cabaret O, Penso Assathiany D, Chosidow O, Botterel F. Un filament peut-il en cacher un autre ?
Société Française de Mycologie Médicale (SFMM). Rennes. 9-11 mai 2012.
29. Cabaret O, Emirian A, Foulet F, Fihman V, Legrand P, Guillot J, Decousser JW, Botterel F. Epidemiology of
respiratory colonization with Aspergillus fumigatus and Stenotrophomonas maltophilia or Pseudomonas aeruginosa:
retrospective study from 2007 to 2011 in a French hospital. 18th Congress of the International Society for Human and
Animal Mycology (ISHAM), 12-16 juin 2012, Berlin, Allemagne
30. Pasquetti M, Gräser Y, Mialot M, Degorce-Rubiales F, Guillot J, Abramo F, Peano A. Use of microsatellite markers for
typing of Microsporum canis isolates causing pseudomycetoma in cats. 18th Congress of the International Society for
Human and Animal Mycology (ISHAM), 12-16 juin 2012, Berlin, Allemagne
31. Peano A, Pasquetti M, Guillot J, Chiavassa E. Antifungal resistance of Malassezia pachydermatis: fact or fiction?
Personal contribution and a literature review. 18th Congress of the International Society for Human and Animal
Mycology (ISHAM), 12-16 juin 2012, Berlin, Allemagne
32. Thierry S, Durand B, Melloul E, Cordonnier N, Tafani JP, Wang DY, Deville M, Chermette R, Guillot J, Arné P.
Assessment of Aspergillus fumigatus pathogenicity in aerosol-challenged chickens (Gallus gallus) belonging to two
lineages. 18th Congress of the International Society for Human and Animal Mycology (ISHAM), 12-16 juin 2012, Berlin,
Allemagne
33. Crosaz O, Hadjaje C, Hahn H, Hubert B, Marignac G, Desquilbet L, Chermette R, Guillot J. MalDESI, an index for the
clinical evaluation of dogs with Malassezia dermatitis. 7th World Congress of Veterinary Dermatology (WCVD) 24-28
juillet 2012, Vancouver, Canada
34. Bensignor E, Hahn H, Guillot J. Topical versus systemic treatment of Malassezia dermatitis in dogs: a comparative,
blinded, randomized trial. 7th World Congress of Veterinary Dermatology (WCVD) 24-28 juillet 2012, Vancouver,
Canada
2013
35. Arné P, Melloul E, Thierry S, Cordonnier N, Chermette R, Botterel F, Bostvironnois C, Guillot J. Pourquoi faut-il
développer des modèles in vivo et in vitro d’aspergillose aviaire ? 10èmes Journées de la Recherche Avicole et
Palmipèdes à Foie Gras. La Rochelle, 26-28 mars 2013
Book editing
1. Lefèvre PC, Blancou J, Chermette R, Uilenberg G. Infectious and parasitic diseases of livestock. Tec & Doc – E M inter,
Lavoisier, Paris 2010
Book chapters
N=12
2009
1) Guillot J. 2009. Diagnostic expérimental des lévuroses. In: Carlotti DN (ed.) L’indispensable de dermatologie canine
et féline, 2ème édition, AFVAC éditions Med’Com, Paris, pp. 127-129.
2010
2) ugita T, Boekhout T, Guillot J, Hadina S, Cabanes J. 2010. Epidemiology. In: Velegraki A, Mayzer P, Guého E,
Boekhout T (eds.) Malassezia and the skin, first edition, Springer, Berlin, pp. 65-119.
3) Bond R, Guillot J, Cabanes J. 2010. Malassezia yeasts in animal diseases. In: Velegraki A, Mayzer P, Guého E,
Boekhout T (eds.) Malassezia and the skin, first edition, Springer, Berlin, pp. 271-299.
4) Chermette R, Guillot J. 2010. General considerations on fungi and fungal diseases. In : « Infectious and parasitic
diseases of livestock » Lefèvre P.C., Blancou J., Chermette R. & Uilenberg G. (Eds). Tec & Doc – E M inter, Lavoisier,
Paris. Volume 2, part 4 Fungal diseases, 1307-1316.
5) Chermette R, Guillot J. 2010. Dermatophytoses. In : « Infectious and parasitic diseases of livestock » Lefèvre P.C.,
Blancou J., Chermette R. & Uilenberg G. (Eds). Tec & Doc – E M inter, Lavoisier, Paris. Volume 2, part 4 Fungal
diseases, 1317-1336.
6) Guillot J, Chermette R. 2010. Aspergillosis. In : « Infectious and parasitic diseases of livestock » Lefèvre P.C.,
Blancou J., Chermette R. & Uilenberg G. (Eds). Tec & Doc – E M inter, Lavoisier, Paris. Volume 2, part 4 Fungal
diseases, 1337-1347.
7) Guillot J, Chermette R. 2010. Mucormycosis. In : « Infectious and parasitic diseases of livestock » Lefèvre P.C.,
Blancou J., Chermette R. & Uilenberg G. (Eds). Tec & Doc – E M inter, Lavoisier, Paris. Volume 2, part 4 Fungal
diseases, 1349-1353.
8) Chermette R, Guillot J. 2010. Candidosis. In : « Infectious and parasitic diseases of livestock » Lefèvre P.C., Blancou
J., Chermette R. & Uilenberg G. (Eds). Tec & Doc – E M inter, Lavoisier, Paris. Volume 2, part 4 Fungal diseases,
1355-1368.
9) Chermette R, Guillot J. 2010. Cryptococcosis. In : « Infectious and parasitic diseases of livestock » Lefèvre P.C.,
Blancou J., Chermette R. & Uilenberg G. (Eds). Tec & Doc – E M inter, Lavoisier, Paris. Volume 2, part 4 Fungal
diseases, 1369-1384.
10) Chermette R, Guillot J. 2010. Mycoses due to dimorphic fungi. In : « Infectious and parasitic diseases of livestock »
Lefèvre P.C., Blancou J., Chermette R. & Uilenberg G. (Eds). Tec & Doc – E M inter, Lavoisier, Paris. Volume 2, part 4
Fungal diseases, 1385-1394.
11) ANOFEL. Parasitoses et mycoses des régions tempérées et tropicales. Coll. Abrégés connaissances et pratique. Ed
Masson 2010 (Françoise Botterel dans le comité de rédaction).
12) Felten A, Botterel F, Vimont S. Microbiologie des liquides de transplantation d’organe avant transplantation. REMIC.
Edition 2010.
Article in journals for professionals
N=31
2008
1) Aliouat MC, Demanche C, Courpon A, Chabé M, Guillot J, Dei-Cas E, Aliouat EM. 2008. Micro-champignons et chauvessouris. Symbioses 21:74.
2) Bretagne S. Posaconazole : un nouvel antifongique pour quelles indications ? Antibiotiques 2008 10;42-49.
3) Guillot J, Ribot X, Chermette R. 2008. Les formes atypiques de dermatophytose équine. Le Nouveau Praticien
Vétérinaire (équine) 16:229-231.
4) Guillot J, Carruel E, Boulouis HJ.. Les parasitoses, les mycoses et les bactérioses rencontrées sous les tropiques chez
le chien et le chat. Le Nouveau Praticien Vétérinaire 2008 8:342-345.
5) Poirier P, Foulet F, Bonoua M, Bories C, Guiguen C, Bretagne S, Botterel F. Myiase à Cordylobia anthropophaga
d’origine sud-africaine. Médecine Tropicale, 2008, 68(1):102-103.
2009
6) Bellanger AP, Reboux G, Roussel S, Botterel F, Dalphin JC, Bretagne S, Millon L. De nouveaux arguments en faveur du
rôle pathogène d’Absidia corymbifera dans la maladie du poumon de fermier. Journal de Mycologie Médicale 2009;
19 (3):206.
7) Bretagne S. De nouvelles molécules pour les infections fongiques ? Antibiotiques 2009, 11:133-141.
8)
Magne D, Angoulvant A, Botterel F, Bouges-Michel C. Bougnoux ME, Bouree P, Brun S, Chochillon C, Cornet M,
Dannaoui E, Datry A, Dunand J, Galeazzi G, Lebuisson A, Sarfati C, Roux P. Réseau pneumocystose francilien : bilan
de cinq années de surveillance (2003/2007). Journal de Mycologie Médicale 2009, 19:290-293.
9) Poirier P, Brugières P, Liance M, Hosseini H, Perignon A, Botterel F. Sciatique après un retour du Mali : à propos d’un
cas de myélopathie bilharzienne. Médecine Tropicale 2009, 69(3):295-297.
2010
10) Alanio A, Bretagne S. Résistance microbiologique des Aspergillus aux antifongiques : de l’identification au
séquençage des mutations. Antibiotiques 2010 12:114-119.
11) Andujar P, Bastuji-Garin S, Botterel F, Prevel M, Farcet JP, Claudepierre P. Factors affecting students performance
on the National Ranking Examination in a French Medical School. La Presse Médicale 2010, 39(6):e134-140.
12) Guillot J. 2010. Infections fongiques ; actualités thérapeutiques. Pratique Vétérinaire, numéro spécial Thérapeutique
en Dermatologie 12.
2011
13) Botterel F, Foulet F. Quoi de neuf en 2010 dans la prise en charge de la gale ? Revue des anti-infectieux. Avril 2011
14) Guillot J, Ruytoor P, Pennant O, Déan E, Dorchies P. 2011. La thélaziose oculaire du chien : un exemple de maladie
parasitaire émergente en France. Pratique médicale et chirurgicale de l’animal de compagnie 46:9-15.
15) Guillot J, Nielsen M, Meana A, Beugnet F. 2011. Les parasites digestifs des Equidés ; Transmission, méthodes de lutte,
chimiorésistance. Merial. 29p.
16) Krief S, Krief JM, Kasenene J, Sévenet T, Hladik CM, Snounou G, Guillot J. 2011. Les grands singes : qui sont-ils ?
sont-ils capables d’automédication ? Bulletin de l’Académie nationale de Médecine 195:1927-1944.
17) Guillot J, Vermeulen B, Lafosse S, Chauffour S, Cibot M, Narat V, Masi S, Nieguitsila A, L’Hostis M, Snounou G, Bain O,
Krief S. 2011. Les nématodes du genre Oesophagostomum ; Un risque émergent pour l’Homme et les grands singes en
Afrique ? Bulletin de l’Académie nationale de Médecine 195:1955-1963.
2012
18) Gangneux JP, Bernard L, Botterel F, Carel A, Castel O, Adjidé CC, Derouin F, Hoarau G, Labussière H, Labussière MH,
Lafaurie M, Millon L, B. Pottecher B, Thiebaut A, Turco M, Baron R. Appréciation quantitative du risque fongique en
cas de travaux en établissements de santé : propositions d’indicateurs d’impact des mesures de gestion du risque
infectieux fongique. Journal de Mycologie Médicale. 2012 ; 22 (1) : 64-71.
19) Guillot J, Bourdoiseau G. 2012. Parasitologie interne des carnivores domestiques. Supplément technique de la
Dépèche Vétérinaire 35 pages.
20) Guillot J. 2012. La lutte anti-vectorielle chez les carnivores domestiques. Le Point Vétérinaire 325:24-27.
21) Gabriel Reboux et coll. Allergies et Habitat - Moisissures et environnement intérieur. Brochures à l’intention des
pneumologues et allergologues. Laboratoire Chiesi. 2012
22) Thierry S, Wang DY, Arné P, Deville M, De Bruin B, Nieguitsila A, Pourcel C, Laroucau K, Chermette R, Huang W,
Botterel F, Guillot J. 2012. Une nouvelle technique de typage moléculaire de la moisissure opportuniste Aspergillus
fumigatus ; application potentielle dans les couvoirs et les élevages avicoles. EuroReference N°6, ER06-12R01.
http://www.anses.fr/ euroreference/numero6/PN5001.htm. 13-15.
2013
23) Bonnal C, Foulet F, Botterel F. Les candiduries. La revue du praticien. 2013
24) Chabanne L, Beugnet F, Guillot J, Bourdoiseau G. 2013. Les maladies vectorielles du chien. Supplément technique de
la Dépêche Vétérinaire. 45 pages.
25) Chartier C, Hoogveld C, Ponnau A, Buret Y, Wild N, Albaric O, Cesbron N, Guillot J, Bourdeau P, Guatteo R, Assie S.
Foyer de mammite aspergillaire dans un troupeau laitier caprin. Bulletin des GTV, sous presse.
26) Guillot J, Bourdoiseau G. 2013. Les étapes du diagnostic et du traitement de la leishmaniose canine : ce que nous
recommandent les experts européens. Pratique Vet, 48 : 128-131.
27) Guillot J, Chermette R. 2013. Les dermatophytsoes du chien. Le Point Vétérinaire, sous presse.
28) Krief S, Cibot M, Bortolamiol S, Lafosse S, Seguya A, Guillot J. Proximités géographiques et phylogénétiques entre les
chimpanzés et les humains et conséquences sanitaires ; exemple du parc national de Kibale en Ouganda. Bulletin de
l’Académie vétérinaire, sous presse.
29) Lebis C, Guillot J. Le diagnostic de la leishmaniose canine. L’Essentiel, mai 2013.
30) Lebis C, Guillot J. L’épidémiologie des babésioses canines. L’Essentiel, mai 2013.
31) Lebis C, Guillot J. Le diagnostic et le traitement de la giardiose chez les carnivores domestiques. L’Essentiel, juin
2013.

Documents pareils